Salarius Pharmaceuticals, Inc. announced that it has received an extension from Nasdaq to regain compliance with its listing requirements, specifically the Equity Standard and Minimum Bid Price ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results